docetaxel anhydrous has been researched along with acetyl coenzyme a in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (acetyl coenzyme a) | Trials (acetyl coenzyme a) | Recent Studies (post-2010) (acetyl coenzyme a) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 3,551 | 14 | 1,291 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, X; Liu, X; Nesa, EU; Niu, H; Tian, K; Xu, Q; Yuan, H; Zhang, X; Zhu, D; Zhu, S | 1 |
1 other study(ies) available for docetaxel anhydrous and acetyl coenzyme a
| Article | Year |
|---|---|
Hyper-acetylation contributes to the sensitivity of chemo-resistant prostate cancer cells to histone deacetylase inhibitor Trichostatin A.
Topics: Acetyl Coenzyme A; Adaptor Proteins, Signal Transducing; Allografts; Animals; Antineoplastic Agents; Apoptosis; Carrier Proteins; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cisplatin; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factors; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Male; Mice; Mice, Inbred C57BL; Phosphoproteins; Prostatic Neoplasms; Protein Isoforms; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Burden | 2018 |